
Researchers target specific protein associated with poor survival and treatment
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with low survival rates, with newly diagnosed patients surviving a median of 14 months and recurrent patients surviving a median of only 3 to 9 months. New ...
Mar 4, 2016
0
47